These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 30370569

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition.
    Shibata Y, Ito K, Suzuki K, Nakano K, Fukabori Y, Suzuki R, Kawabe Y, Honma S, Yamanaka H.
    Prostate; 2000 Jan; 42(1):45-55. PubMed ID: 10579798
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
    Drafta D, Proca E, Zamfir V, Schindler AE, Neacşu E, Stroe E.
    J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
    [Abstract] [Full Text] [Related]

  • 8. Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease.
    Grosman H, Fabre B, Lopez M, Scorticati C, Lopez Silva M, Mesch V, Mazza O, Berg G.
    Aging Male; 2016 Dec; 19(1):40-5. PubMed ID: 26526283
    [Abstract] [Full Text] [Related]

  • 9. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y, Ye L, Ding Q, Fang Z, Yao M, Shi D.
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.
    Tan MO, Karabiyik I, Uygur MC, Diker Y, Erol D.
    Int Urol Nephrol; 2003 Jul; 35(3):357-63. PubMed ID: 15160539
    [Abstract] [Full Text] [Related]

  • 13. Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma.
    Lukkarinen O, Hammond GL, Kontturi M, Vihko R.
    Scand J Urol Nephrol; 1980 Jul; 14(3):225-7. PubMed ID: 6163202
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
    Meikle AW, Stephenson RA, Lewis CM, Wiebke GA, Middleton RG.
    Prostate; 1997 Oct 01; 33(2):105-11. PubMed ID: 9316651
    [Abstract] [Full Text] [Related]

  • 16. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R, Puah CM.
    J Endocrinol; 1981 Feb 01; 88(2):255-62. PubMed ID: 6162906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
    Becker C, Piironen T, Pettersson K, Björk T, Wojno KJ, Oesterling JE, Lilja H.
    J Urol; 2000 Jan 01; 163(1):311-6. PubMed ID: 10604382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.